Javascript must be enabled to continue!
Clinical analysis on interventional treatmen for patients with ostium secundum defect
View through CrossRef
Objective
To evaluate the clinical efficacy of interventional therapy for patients with ostium secundum atrial septal defect (ASD).
Methods
One hundred and fifty patients (male-90, female-60), age at 2–71 (12±5) years old. Diagnosis as ostium secundum defect by transthoracic echocardiography (TTE), measuring different facets of ASD, the maximal diameters were 4–36(20±6)mm. Single-hole-type-ASD were 145 cases, porous-type were five cases. Meanwhile, combined with PDA were two cases, with PS was one case. Guiding by transthoracic ultrasound, we implanted a domestic Amplatzer-occluder (Beijing Huayi shengjie). After operation, patients were regularly follow-up by cardiac ultrasound and clinical examination.
Results
One hundred and fifty cases were all successfully blocked, the occluder diameters were at 6–40 (23±2) mm. Intraoperative, the systolic pressure of pulmonary artery were at 25–65 (30±4)mm Hg. Three cases of porous-type ASD, we used a single occluder; another two cases we each used two occlusion devices to block two defect holes. Two cases with PDA and one case with PS all completed the intervention therapy. Intraoperative, there was no residual shunt. Following-up from 1 month to 5 years, there were no occluder shedding, no complications of thrombosis and endocarditis. Atrio-ventricular sises were reduced to different degrees.
Conclusion
The interventional treatment for patients with ostium secundum defect was convenient, minimally invasive, safe and high success rate, affirmative curative effect, and could be the first treatment measures for secundum ostium secundum atrial septal defect (ASD).
Title: Clinical analysis on interventional treatmen for patients with ostium secundum defect
Description:
Objective
To evaluate the clinical efficacy of interventional therapy for patients with ostium secundum atrial septal defect (ASD).
Methods
One hundred and fifty patients (male-90, female-60), age at 2–71 (12±5) years old.
Diagnosis as ostium secundum defect by transthoracic echocardiography (TTE), measuring different facets of ASD, the maximal diameters were 4–36(20±6)mm.
Single-hole-type-ASD were 145 cases, porous-type were five cases.
Meanwhile, combined with PDA were two cases, with PS was one case.
Guiding by transthoracic ultrasound, we implanted a domestic Amplatzer-occluder (Beijing Huayi shengjie).
After operation, patients were regularly follow-up by cardiac ultrasound and clinical examination.
Results
One hundred and fifty cases were all successfully blocked, the occluder diameters were at 6–40 (23±2) mm.
Intraoperative, the systolic pressure of pulmonary artery were at 25–65 (30±4)mm Hg.
Three cases of porous-type ASD, we used a single occluder; another two cases we each used two occlusion devices to block two defect holes.
Two cases with PDA and one case with PS all completed the intervention therapy.
Intraoperative, there was no residual shunt.
Following-up from 1 month to 5 years, there were no occluder shedding, no complications of thrombosis and endocarditis.
Atrio-ventricular sises were reduced to different degrees.
Conclusion
The interventional treatment for patients with ostium secundum defect was convenient, minimally invasive, safe and high success rate, affirmative curative effect, and could be the first treatment measures for secundum ostium secundum atrial septal defect (ASD).
Related Results
Small Cell Lung Cancer and Tarlatamab: A Meta-Analysis of Clinical Trials
Small Cell Lung Cancer and Tarlatamab: A Meta-Analysis of Clinical Trials
Abstract
Introduction
Tarlatamab is a Delta-like ligand 3 (DLL3) -directed bispecific T-cell engager recently approved for use in patients with advanced small cell lung cancer (SCL...
Social media in interventional radiology
Social media in interventional radiology
AbstractIntroductionSocial media provides opportunities for Interventional Radiologists to share research, communicate with colleagues, provide health information and advertise the...
Autonomy on Trial
Autonomy on Trial
Photo by CHUTTERSNAP on Unsplash
Abstract
This paper critically examines how US bioethics and health law conceptualize patient autonomy, contrasting the rights-based, individualist...
Differences in Coronary Alignment Between Evolut FX and Navitor Valves
Differences in Coronary Alignment Between Evolut FX and Navitor Valves
ABSTRACT
Background
Ensuring coronary access is essential for lifetime management after transcatheter aortic valve replac...
Poster 107: The Use of Coacervate Sustained Release System to Identify the Most Potent BMP for Bone Regeneration
Poster 107: The Use of Coacervate Sustained Release System to Identify the Most Potent BMP for Bone Regeneration
Objectives: Bone morphogenetic proteins (BMPs) belong to the transforming growth factor superfamily that were first discovered by Marshall Urist. There are 14 BMPs identified to da...
Carcinoma ex Pleomorphic Adenoma: A Case Series and Literature Review
Carcinoma ex Pleomorphic Adenoma: A Case Series and Literature Review
Abstract
Introduction
Carcinoma ex pleomorphic adenoma (CXPA) is a rare malignant salivary gland tumor that can lead to severe complications and carries a risk of distant metastasi...
Pembrolizumab and Sarcoma: A meta-analysis
Pembrolizumab and Sarcoma: A meta-analysis
Abstract
Introduction: Pembrolizumab is a monoclonal antibody that promotes antitumor immunity. This study presents a systematic review and meta-analysis of the efficacy and safety...
ASSA13-17-8 Interventional Therapy of Combined Congenital Heart Disease
ASSA13-17-8 Interventional Therapy of Combined Congenital Heart Disease
Objective
To evaluate the interventional therapeutic strategy and effect of one-stage interventional therapy of 109 patients’ with combined congenital heart idsea...

